
PIK3CA Oncogenic Mutations in Breast and Colon Cancers: Development of Targeted Anticancer Drugs and Diagnostics
Project title: PIK3CA Oncogenic Mutations in Breast and Colon Cancers: Development of Targeted Anticancer Drugs and Diagnostics
Coordinator: Dr. Argiris Efstratiadis; BRF Academy of Athens
Funding: OPERATIONAL PROGRAMMES 'COMPETITIVENESS & ENTREPRENEURSHIP' National Strategic Reference Framework NSRF 2007-1013 National Action: 'COOPERATION', Sub-action II: 'Large Scale Cooperative Projects
Total Budget: 2.453.625 €
Tags: drug discovery